HUTCHMED (China) HCM
NASDAQ HCM
$12.58 -0.01 (-0.08%)
As of: Aug 20, 2026 · 3:59 PM EDT

HUTCHMED (China) (HCM) EBT Growth (3y) (2018 - 2021)

HUTCHMED (China) (HCM) EBT Growth (3y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 21.00%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.19%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 3.60%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -29.91%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 10.08%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 39.40%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 HUTCHMED (China) 2.18 Bn 2.18 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -134.81%
Mar 31, 2021 -38.13%
Jun 30, 2019 -69.95%
Jun 30, 2018 38.91%